How PBRER has changed the data requirements for Life Sciences companies


This complimentary webinar hosted by ArisGlobal addresses the new data requirements outlined in the Periodic Benefit-Risk Evaluation Report (PBRER) on marketed products (including approved drugs that are under further study) among the ICH regions. In this webinar, Christian Moorman- Senior Director, Leading Practices @ ArisGlobal also discusses the recommended format and content of a PBRER and provides an outline of points to be considered in its preparation and submission.

Please fill in the below form to view the webinar recording.

 

* denotes required field